Cargando…
Progress and pitfalls of a year of drug repurposing screens against COVID-19()
Near the end of 2019, a new betacoronavirus started to efficiently transmit between humans, resulting in the current COVID-19 pandemic. Unprecedented worldwide efforts were made to identify and repurpose antiviral therapeutics from collections of approved drugs and known bioactive compounds. Typical...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214175/ https://www.ncbi.nlm.nih.gov/pubmed/34218010 http://dx.doi.org/10.1016/j.coviro.2021.06.004 |